Cargando…

Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy – an epidemiological study using validated EUROCAT data

BACKGROUND: Previous studies suggest a possible association between maternal use of selective serotonin-reuptake inhibitors (SSRIs) during early pregnancy and congenital heart defects (CHD). The purpose of this study was to verify this association by using validated data from the Danish EUROCAT Regi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knudsen, Tanja Majbrit, Hansen, Anne Vinkel, Garne, Ester, Andersen, Anne-Marie Nybo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183770/ https://www.ncbi.nlm.nih.gov/pubmed/25258023 http://dx.doi.org/10.1186/1471-2393-14-333

Ejemplares similares

Registries of congenital anomalies: EUROCAT.
por: Lechat, M F, et al.
Publicado: (1993)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark
por: Jordan, Sue, et al.
Publicado: (2016)

Multilevel analyses of related public health indicators: The European Surveillance of Congenital Anomalies (EUROCAT) Public Health Indicators
por: Best, Kate E., et al.
Publicado: (2020)

Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study
por: Nembhard, Wendy N, et al.
Publicado: (2017)

Non-occupational exposure to paint fumes during pregnancy and risk of congenital anomalies: a cohort study
por: Hjortebjerg, Dorrit, et al.
Publicado: (2012)

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring
por: Olivier, J. D. A., et al.
Publicado: (2013)

Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study
por: Garne, E, et al.
Publicado: (2016)

Detection and investigation of temporal clusters of congenital anomaly in Europe: seven years of experience of the EUROCAT surveillance system
por: Dolk, Helen, et al.
Publicado: (2015)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study
por: Jimenez-Solem, Espen, et al.
Publicado: (2012)

Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies
por: Wang, Shang, et al.
Publicado: (2015)

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
por: Pedersen, Lars Henning, et al.
Publicado: (2009)

Maternal risk factors for the VACTERL association: A EUROCAT case–control study
por: van de Putte, Romy, et al.
Publicado: (2020)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Prevalence of vascular disruption anomalies and association with young maternal age: A EUROCAT study to compare the United Kingdom with other European countries
por: Morris, Joan K., et al.
Publicado: (2022)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?
por: Daud, Aizati N. A., et al.
Publicado: (2016)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis
por: Kornum, Jette B, et al.
Publicado: (2010)

Educational disparities in perinatal health in Denmark in the first decade of the 21st century: a register-based cohort study
por: Bilsteen, Josephine Funck, et al.
Publicado: (2018)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Mode of delivery is not associated with celiac disease
por: Dydensborg Sander, Stine, et al.
Publicado: (2018)

Suicidality and self‐injury with selective serotonin reuptake inhibitors in youth: Occurrence, predictors and timing
por: Sørensen, Johanne Østerby, et al.
Publicado: (2021)

Reduced anxiety is associated with the accumulation of six serotonin reuptake inhibitors in wastewater treatment effluent exposed goldfish Carassius auratus
por: Simmons, D. B. D., et al.
Publicado: (2017)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study
por: Reis, Margareta, et al.
Publicado: (2013)

Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
por: Vahid-Ansari, Faranak, et al.
Publicado: (2019)

Improving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers: A EUROmediCAT Study
por: de Jonge, Linda, et al.
Publicado: (2015)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Briley, Mike, et al.
Publicado: (2010)

Prenatal exposure to serotonin reuptake inhibitors: a case report
por: Marsella, Maria, et al.
Publicado: (2010)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gf344oku7s7fqbk01fvvru4b0j